GRAIL INC (GRAL) Fundamental Analysis & Valuation

NASDAQ:GRAL • US3847471014

Current stock price

50.65 USD
-1.95 (-3.71%)
At close:
50.65 USD
0 (0%)
After Hours:

This GRAL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GRAL Profitability Analysis

1.1 Basic Checks

  • In the past year GRAL has reported negative net income.
  • In the past year GRAL has reported a negative cash flow from operations.
  • In the past 5 years GRAL always reported negative net income.
  • GRAL had a negative operating cash flow in each of the past 5 years.
GRAL Yearly Net Income VS EBIT VS OCF VS FCFGRAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2021 2022 2023 2024 2025 -1B -2B -3B -4B -5B

1.2 Ratios

  • GRAL has a Return On Assets of -13.97%. This is in the better half of the industry: GRAL outperforms 78.88% of its industry peers.
  • Looking at the Return On Equity, with a value of -15.84%, GRAL belongs to the top of the industry, outperforming 83.91% of the companies in the same industry.
Industry RankSector Rank
ROA -13.97%
ROE -15.84%
ROIC N/A
ROA(3y)-39.79%
ROA(5y)-48.3%
ROE(3y)-45.67%
ROE(5y)-53.29%
ROIC(3y)N/A
ROIC(5y)N/A
GRAL Yearly ROA, ROE, ROICGRAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • With a decent Gross Margin value of 48.46%, GRAL is doing good in the industry, outperforming 73.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GRAL has grown nicely.
  • The Profit Margin and Operating Margin are not available for GRAL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.56%
GM growth 5YN/A
GRAL Yearly Profit, Operating, Gross MarginsGRAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. GRAL Health Analysis

2.1 Basic Checks

  • GRAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • GRAL has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for GRAL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GRAL Yearly Shares OutstandingGRAL Yearly Shares OutstandingYearly Shares Outstanding 2019 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GRAL Yearly Total Debt VS Total AssetsGRAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of -1.32, we must say that GRAL is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.32, GRAL is in line with its industry, outperforming 51.55% of the companies in the same industry.
  • There is no outstanding debt for GRAL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.32
ROIC/WACCN/A
WACC9.55%
GRAL Yearly LT Debt VS Equity VS FCFGRAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • GRAL has a Current Ratio of 11.97. This indicates that GRAL is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 11.97, GRAL belongs to the best of the industry, outperforming 85.08% of the companies in the same industry.
  • GRAL has a Quick Ratio of 11.97. This indicates that GRAL is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 11.97, GRAL belongs to the best of the industry, outperforming 85.08% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.97
Quick Ratio 11.97
GRAL Yearly Current Assets VS Current LiabilitesGRAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GRAL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 83.10% over the past year.
  • GRAL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.18%.
  • The Revenue has been growing by 38.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)83.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.15%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y38.37%
Revenue growth 5YN/A
Sales Q2Q%13.97%

3.2 Future

  • GRAL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.43% yearly.
  • The Revenue is expected to grow by 26.67% on average over the next years. This is a very strong growth
EPS Next Y-0.69%
EPS Next 2Y0.49%
EPS Next 3Y1.16%
EPS Next 5Y7.43%
Revenue Next Year22.22%
Revenue Next 2Y24.28%
Revenue Next 3Y26.32%
Revenue Next 5Y26.67%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
GRAL Yearly Revenue VS EstimatesGRAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
GRAL Yearly EPS VS EstimatesGRAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

0

4. GRAL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GRAL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRAL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRAL Price Earnings VS Forward Price EarningsGRAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRAL Per share dataGRAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.49%
EPS Next 3Y1.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GRAL Dividend Analysis

5.1 Amount

  • No dividends for GRAL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GRAL Fundamentals: All Metrics, Ratios and Statistics

GRAIL INC

NASDAQ:GRAL (4/23/2026, 4:15:05 PM)

After market: 50.65 0 (0%)

50.65

-1.95 (-3.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-19
Earnings (Next)05-11
Inst Owners73.86%
Inst Owner Change-0.04%
Ins Owners0.86%
Ins Owner Change-25.88%
Market Cap2.08B
Revenue(TTM)147.17M
Net Income(TTM)-408.35M
Analysts81.67
Price Target85.07 (67.96%)
Short Float %18.3%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.52%
Min EPS beat(2)11.6%
Max EPS beat(2)31.44%
EPS beat(4)4
Avg EPS beat(4)20.33%
Min EPS beat(4)11.6%
Max EPS beat(4)31.44%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-2.15%
Max Revenue beat(2)0.24%
Revenue beat(4)1
Avg Revenue beat(4)-5.12%
Min Revenue beat(4)-11.33%
Max Revenue beat(4)0.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.51%
PT rev (3m)-20.57%
EPS NQ rev (1m)0.54%
EPS NQ rev (3m)5.81%
EPS NY rev (1m)-0.62%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)-0.34%
Revenue NQ rev (3m)3.5%
Revenue NY rev (1m)-1.38%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.12
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB 2.86
EV/EBITDA N/A
EPS(TTM)-11.18
EYN/A
EPS(NY)-11.26
Fwd EYN/A
FCF(TTM)-7.31
FCFYN/A
OCF(TTM)-7.29
OCFYN/A
SpS3.59
BVpS62.84
TBVpS17.73
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -13.97%
ROE -15.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.46%
FCFM N/A
ROA(3y)-39.79%
ROA(5y)-48.3%
ROE(3y)-45.67%
ROE(5y)-53.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.56%
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.58%
Cap/Sales 0.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.97
Quick Ratio 11.97
Altman-Z -1.32
F-Score6
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)4%
Cap/Depr(5y)29.28%
Cap/Sales(3y)6.2%
Cap/Sales(5y)107.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.15%
EPS Next Y-0.69%
EPS Next 2Y0.49%
EPS Next 3Y1.16%
EPS Next 5Y7.43%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y38.37%
Revenue growth 5YN/A
Sales Q2Q%13.97%
Revenue Next Year22.22%
Revenue Next 2Y24.28%
Revenue Next 3Y26.32%
Revenue Next 5Y26.67%
EBIT growth 1Y30.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.44%
EBIT Next 3Y10.91%
EBIT Next 5Y7.77%
FCF growth 1Y48.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.19%
OCF growth 3YN/A
OCF growth 5YN/A

GRAIL INC / GRAL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GRAIL INC?

ChartMill assigns a fundamental rating of 4 / 10 to GRAL.


What is the valuation status of GRAIL INC (GRAL) stock?

ChartMill assigns a valuation rating of 0 / 10 to GRAIL INC (GRAL). This can be considered as Overvalued.


Can you provide the profitability details for GRAIL INC?

GRAIL INC (GRAL) has a profitability rating of 2 / 10.